Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma

Gold glyconanoparticles loaded with the listeriolysin O peptide 91–99 (GNP-LLO(91-99)), a bacterial peptide with anti-metastatic properties, are vaccine delivery platforms facilitating immune cell targeting and increasing antigen loading. Here, we present proof of concept analyses for the considerat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Terán-Navarro, Hector, Calderon-Gonzalez, Ricardo, Salcines-Cuevas, David, García, Isabel, Marradi, Marco, Freire, Javier, Salmon, Erwan, Portillo-Gonzalez, Mar, Frande-Cabanes, Elisabet, García-Castaño, Almudena, Martinez-Callejo, Virginia, Gomez-Roman, Javier, Tobes, Raquel, Rivera, Fernando, Yañez-Diaz, Sonsoles, Álvarez-Domínguez, Carmen
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6343812/
https://ncbi.nlm.nih.gov/pubmed/30713801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1541534
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires